Starboard has acquired a "sizable" stake in Kenvue and is pushing for changes to boost the consumer-products company's share price. Kenvue's stock has lagged behind peers over the past year.

Kenvue shares jumped 5% after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the Listerine maker, and wants changes made to boost the stock price. Read on ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights.

Activist investor Starboard Value, which in recent months has taken stakes in coffee chain Starbucks (SBUX) and pharmaceutical giant Pfizer (PFE), has set its sights on Kenvue (KVUE). The Wall ...

Shares of Kenvue rose more than 5% in premarket trading Monday after The Wall Street Journal reported that activist investor Starboard Value has built a sizable stake in the consumer-products ...

Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc KVUE, the company behind popular consumer products like Tylenol and Listerine. Despite having some ...

Oct 20 (Reuters) - Hedge fund Starboard Value has taken a stake in Kenvue (KVUE.N), opens new tab, the consumer products company that makes Band-Aid, Listerine, and Tylenol, and which went public ...

Activist investor Starboard Value reportedly took a stake in wide-moat Kenvue, according to reports from The Wall Street Journal. Kenvue stock was lifted on the news with shares up over 6% at the ...

Activist investor Starboard Value has taken a sizeable stake in Kenvue Inc., the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night. The Wall Street Journal ...

The board of Kenvue Inc. (NYSE:KVUE) has announced that it will pay a dividend of $0.205 per share on the 27th of November. This means the annual payment is 3.8% of the current stock price ...

They want to be part of something meaningful, says Luani Alvarado, chief people officer at Kenvue, the world’s largest pure-play consumer health company by revenue. “The skilled workforce [is ...

In this update, I share my latest thoughts on Kenvue stock, focusing specifically on the Q2 2024 results that sent the stock soaring 25%. I've incorporated the latest results into my valuation ...